Sulfasalazine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6974 publications
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.
Journal: Journal of internal medicine
Published: April 07, 2026
DMARDs and gout therapy in patients with chronic arthritis and end-stage renal disease: a descriptive guide.
Journal: Acta clinica Belgica
Published: April 05, 2026
Corrigendum to "Probiotic-drug co-delivery system enhances sulfasalazine activation for inflammatory bowel disease therapy" [Mater. Today Bio, 36 (2026) 102669].
Journal: Materials today. Bio
Published: April 02, 2026
Effect of monotherapy with conventional synthetic disease-modifying anti-rheumatic drugs or glucocorticoids on radiographic progression in rheumatoid arthritis: a network meta-analysis of 64 treatment arms from 31 randomized controlled trials.
Journal: Scandinavian journal of rheumatology
Published: March 20, 2026
Development and optimization of sulfasalazine loaded microemulsion for improved topical treatment of psoriasis.
Journal: Therapeutic delivery
Published: February 18, 2026
Microbiome-driven PKs: redefining drug metabolism beyond host enzymes.
Journal: Expert opinion on drug metabolism & toxicology
Published: February 16, 2026
Quality by design-driven approach to develop a nanocarrier-based sulfasalazine topical system for rheumatoid arthritis management.
Journal: Drug development and industrial pharmacy
Published: February 11, 2026
Protection by maslinic acid against cisplatin-induced ototoxicity: rescue of ferroptosis by targeting the SLC7A11-GSH-GPX4 pathway.
Journal: Biochemical and biophysical research communications
Published: January 30, 2026
Ethnopharmacological basis and combined protection of intestinal barrier function by fucoidan from Sargassum thunbergii and chito-oligosaccharides in DSS-induced colitis.
Journal: Journal of ethnopharmacology
Published: January 29, 2026
CaCO3-assisted engineering of NIR-II phototheranostics enables photothermally enhanced ferroptosis in cancer through synergistically depleting intracellular glutathione.
Journal: Nanoscale horizons
Published: January 27, 2026
Last Updated: 04/28/2026